This study compares a simple blood test (Prospera) to the standard heart biopsy for monitoring rejection in heart transplant patients. About 250 adults waiting for or who have received a heart transplant will be randomly assigned to one of two monitoring methods. The goal is to s…
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC